[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337609-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337609-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","validation-of-cdc45-as-a-novel-biomarker-for-diagnosis-and-prognosis-of-gastric-cancer","Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer","","CDC45 (cell division cycle protein 45) is implicated in the progression of multiple malignancies, yet its clinical value in gastric cancer has not been established. Using TCGA and TCGA & GTEx, this study compares CDC45 mRNA between gastric cancer and adjacent/normal tissues and validates results across multiple GEO datasets and by RT-qPCR. Human Protein Atlas and immunohistochemistry assess protein expression. ROC/AUC evaluate diagnostic performance, while Kaplan–Meier and multiple cohorts confirm prognostic significance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/validation-of-cdc45-as-a-novel-biomarker-for-diagnosis-and-prognosis-of-gastric-cancer/337609/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/validation-of-cdc45-as-a-novel-biomarker-for-diagnosis-and-prognosis-of-gastric-cancer/337609.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main aim of validating CDC45 in gastric cancer?","Question",{"text":63,"@type":64},"To determine whether CDC45 can serve as a diagnostic and prognostic biomarker for gastric cancer based on RNA and protein expression and clinical outcome associations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets and techniques are used to compare CDC45 expression?",{"text":68,"@type":64},"The study uses TCGA and TCGA & GTEx for mRNA comparisons, validates across multiple GEO datasets, and applies RT-qPCR. Protein expression is evaluated using the Human Protein Atlas and immunohistochemistry.",{"name":70,"@type":61,"acceptedAnswer":71},"How is CDC45 assessed for diagnosis and prognosis?",{"text":72,"@type":64},"Diagnostic utility is evaluated with ROC curves and AUC in TCGA and further validated in TCGA & GTEx and GSE66229. Prognostic importance is analyzed using Kaplan–Meier in TCGA and confirmed in additional datasets.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337609,1790146378,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Submitted 25 October 2023 Accepted 27 February 2024 Published 18 March 2024  \nCorresponding authors  \nLihua Wu, [wulihua0812@163.com](wulihua0812@163.com)[ ](wulihua0812@163.com)Yongqi Shen, [gxnnsyq@163.com](gxnnsyq@163.com)  \nAcademic editor Nitin Amdare  \nAdditional Information and Declarations can be found on page 17  \nDOI 10.7717/peerj.17130  \nCopyright 2024 Wu et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nValidation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer  \nLihua Wu 1, *, Gan Gao2,3, *, Hui Mi4, Zhou Luo 1, Zheng Wang 1, Yongdong Liu 1, Liangyan Wu 1, Haihua Long1 and Yongqi Shen 1  \n1 Afﬁliated Liutie Central Hospital of Guangxi Medical University, Liuzhou, China  \n2 Clinical Laboratory, Liuzhou Hospital of Guangzhou Women and Children’s Medical Center, Liuzhou, Guangxi, China  \n3 Guangxi Clinical Research Center for Obstetrics and Gynecology, liuzhou, Guangxi, China  \n4 Changzhi People’s Hospital, Changzhi, china  \n* These authors contributed equally to this work.  \nABSTRACT  \nBackground: Cell division cycle protein 45 (CDC45) has been demonstrated to play vital roles in the progression of various malignancies. However, the clinical signiﬁcance of CDC45 in gastric cancer (GC) remains unreported.  \nMethod: In this study, we employed the TCGA database and the TCGA & GTEx dataset to compare the mRNA expression levels of CDC45 between gastric cancer tissues and adjacent or normal tissues (p \u003C 0.05 was considered statistically signiﬁcant), which was further validated in multiple datasets including GSE13911, GSE29272, GSE118916, GSE66229, as well as RT-qPCR. Furthermore, we harnessed the Human Protein Atlas (HPA) to evaluate the protein expression of CDC45, which was subsequently veriﬁed through immunohistochemistry (IHC) . To ascertain the diagnostic utility of CDC45, receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) were calculated in TCGA database, and further validated it in TCGA & GTEx and GSE66229 datasets. The Kaplan–Meier method was used to reveal the prognostic importance of CDC45 in The Cancer Genome Atlas (TCGA) database and authenticated through the GSE66229, GSE84433, and GSE84437 datasets. Through cBioPortal, we identiﬁed co-expressed genes of CDC45, and pursued enrichment analysis. Additionally, we availed gene set enrichment analysis (GSEA) to annotate the biological functions of CDC45 .  \nResults: Differential expression analysis revealed that CDC45 was signiﬁcantly upregulated at both the mRNA and protein levels in GC (all p \u003C 0.05) . Remarkably, CDC45 emerged as a promising prognostic indicator and a novel diagnostic biomarker for GC. In a comprehensive the drug susceptibility analysis, we found that patients with high expression of CDC45 had high sensitivity to various chemotherapeutic agents, among which 5-ﬂuorouracil, docetaxel, cisplatin, andelesclomol were most evident. Furthermore, our ﬁndings suggested a plausible association between CDC45 and immune cell inﬁltration. Enrichment analysis revealed that CDC45 and its associated genes may play crucial roles in muscle biofunction, whereas GSEA demonstrated signiﬁcant enrichment of gene sets pertaining to G protein-coupled receptor ligand binding and G alpha (i) signaling events.  \nHow to cite this article Wu L, Gao G, Mi H, Luo Z, Wang Z, Liu Y, Wu L, Long H, Shen Y. 2024. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer. PeerJ 12:e17130 DOI 10.7717/peerj.17130  \nConclusion: Our study elucidates that upregulation of CDC45 is intricately associated with immune cell inﬁltration and holds promising potential as a favorable prognostic marker and a novel diagnostic biomarker for GC.  \nSubjects Computational Biology, Genomics, Gastroenterology and Hepatology, Oncology  \nKeywords Gastric cancer, CDC45, Biomarker, Diagnostic, Biomarker INTRODUCTION  \nGastric cancer (GC) emerges as a prevailing malignancy in the gastrointestinal tract, posing","cbCaijYSVZCFKn73","https://ap.wps.com/l/cbCaijYSVZCFKn73","pdf",20211318,21,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main aim of validating CDC45 in gastric cancer?\",\"answer\":\"To determine whether CDC45 can serve as a diagnostic and prognostic biomarker for gastric cancer based on RNA and protein expression and clinical outcome associations.\"},{\"question\":\"Which datasets and techniques are used to compare CDC45 expression?\",\"answer\":\"The study uses TCGA and TCGA \\u0026 GTEx for mRNA comparisons, validates across multiple GEO datasets, and applies RT-qPCR. Protein expression is evaluated using the Human Protein Atlas and immunohistochemistry.\"},{\"question\":\"How is CDC45 assessed for diagnosis and prognosis?\",\"answer\":\"Diagnostic utility is evaluated with ROC curves and AUC in TCGA and further validated in TCGA \\u0026 GTEx and GSE66229. Prognostic importance is analyzed using Kaplan–Meier in TCGA and confirmed in additional datasets.\"}]","Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer | PDF",1790019777,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fefdc1b68fe361964f4529500310e7d4.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d98e8708a0c7c5f8bc03dd952668f2b0.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acb3458b5f2e86b7a1881eda06ed67df.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6e8ee094b92960aa3b2dabaa4bda8af.webp",980,1268]